$492.76
0[0.00%]
At close: Apr 30
$492.76
0[0.00%]
PreMarket: 4:02PM EDT
IDEXX Laboratories
(NASDAQ:IDXX)Latest News for IDEXX Laboratories Stock (NASDAQ:IDXX)
IDEXX Laboratories Stock (NASDAQ: IDXX)
Categories: All
Wednesday, May 01, 2024
- IDEXX Laboratories Sees FY24 EPS $10.82-$11.20 Vs $12.69 EstimateBenzinga Newsdesk - 14 minutes ago
- IDEXX Laboratories Sees FY24 Revenue Growth 6.5%-8.5%Benzinga Newsdesk - 20 minutes ago
- IDEXX Laboratories Q1 2024 Adj EPS $2.81 Beats $2.67 Estimate, Sales $964.00M Miss $966.13M EstimateBenzinga Newsdesk - 21 minutes ago
Friday, April 26, 2024
Thursday, April 25, 2024
Tuesday, April 16, 2024
Monday, April 01, 2024
Wednesday, March 27, 2024
Monday, March 11, 2024
Tuesday, February 27, 2024
Monday, February 19, 2024
Thursday, February 08, 2024
Tuesday, February 06, 2024
- Where IDEXX Laboratories Stands With AnalystsBenzinga Insights - Feb 6, 2024, 2:00PM
- JP Morgan Maintains Overweight on IDEXX Laboratories, Raises Price Target to $630Benzinga Newsdesk - Feb 6, 2024, 1:59PM
- Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $655Benzinga Newsdesk - Feb 6, 2024, 10:45AM
Monday, February 05, 2024
- Stocks Fall As Traders Dial Back Rate Cut Bets; Dollar, Treasury Yields Rise: What's Driving Markets Monday?Piero Cingari - Feb 5, 2024, 2:12PM
- Why Is Animal Diagnostic-Focused IDEXX Laboratories Stock Trading Higher Today?Vandana Singh - Feb 5, 2024, 1:20PM
- A Closer Look at IDEXX Laboratories's Options Market DynamicsBenzinga Insights - Feb 5, 2024, 12:45PM
- IDEXX Laboratories shares are trading higher after the company reported better-than-expected Q4 results.Benzinga Newsdesk - Feb 5, 2024, 10:26AM
- IDEXX Laboratories Forecasts FY24 EPS Of $10.84-$11.33 Versus Consensus Of $11.00, Reflecting Reported And Organic Growth Of 8%-13%Benzinga Newsdesk - Feb 5, 2024, 6:38AM
- IDEXX Laboratories Forecasts FY24 Sales Of $3.93B-$4.04B Versus Consensus Of $3.97B, Reflecting Full Year Growth Of 7.5%-10.5% As Reported And 7%-10% On An Organic BasisBenzinga Newsdesk - Feb 5, 2024, 6:36AM
- IDEXX Laboratories Q4 Adjusted PS $2.34 Beats $2.12 Estimate, Sales $901.60M Beat $891.25M EstimateBenzinga Newsdesk - Feb 5, 2024, 6:32AM
- Earnings Scheduled For February 5, 2024Benzinga Insights - Feb 5, 2024, 5:20AM
Friday, February 02, 2024
Tuesday, January 30, 2024
Wednesday, January 17, 2024
Tuesday, January 16, 2024
Friday, January 12, 2024
Monday, January 08, 2024
Tuesday, December 19, 2023
Wednesday, December 13, 2023
Thursday, December 07, 2023
Monday, December 04, 2023
Monday, November 20, 2023
Thursday, November 09, 2023
Tuesday, November 07, 2023
Monday, November 06, 2023
Friday, November 03, 2023
- Shares of healthcare equipment and healthcare provider stocks are trading higher amid overall market strength. Strength may also be attributed to Cardinal Health after the company reported better-than-expected Q1 financial results.Benzinga Newsdesk - Nov 3, 2023, 3:33PM
- 5 Analysts Have This to Say About IDEXX LaboratoriesBenzinga Insights - Nov 3, 2023, 11:00AM
- Goldman Sachs Maintains Buy on IDEXX Laboratories, Lowers Price Target to $500Benzinga Newsdesk - Nov 3, 2023, 10:42AM
Thursday, November 02, 2023
- JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $550Benzinga Newsdesk - Nov 2, 2023, 5:44PM
- IDEXX Laboratories shares are trading higher after Barclays maintained an Overweight rating on the stock and raised its price target from $590 to $592.Benzinga Newsdesk - Nov 2, 2023, 12:07PM
- Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $592Benzinga Newsdesk - Nov 2, 2023, 11:21AM
Wednesday, November 01, 2023
- Is There An Opportunity To Buy IDEXX Labs, The Animal Diagnostics-Focused Firm Stock After Q3 Performance? Analyst AnswersVandana Singh - Nov 1, 2023, 12:32PM
- IDEXX Laboratories shares are trading lower after the company reported a Q3 revenue miss and lowered its FY23 revenue guidance.Benzinga Newsdesk - Nov 1, 2023, 11:18AM
- Earnings Scheduled For November 1, 2023Benzinga Insights - Nov 1, 2023, 7:19AM